SCHEMBL2478342

SCHEMBL2478342

CN(C)CCc1cncc(Br)c1.CN1CCN(CCc2cncc(Br)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.42
TAAR1 Q96RJ0 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
TACR1 P25103 1/20 0.39
SLC6A4 P31645 1/20 0.39
KCNH2 Q12809 1/20 0.39
CHRNA7 P36544 1/20 0.37
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2258099 0.90 SIGMAR1 (0.46) SIGMAR1CYP1A2CYP2D6TMEM97TACR1
SCHEMBL2260183 0.83 TAAR1 (0.55) TAAR1CHRNA7HCRTR1HCRTR2
SCHEMBL112800 0.77 MC4R (0.47) TACR1SLC6A4KCNH2
SCHEMBL29933818 0.77 MC4R (0.47) TACR1SLC6A4KCNH2
SCHEMBL2256078 0.75 SIGMAR1 (0.49) SIGMAR1CYP2D6
SCHEMBL30419289 0.74 SIGMAR1 (0.47) SIGMAR1CYP1A2CYP2D6TMEM97
SCHEMBL18474496 0.74 NOS3 (0.50) SIGMAR1TAAR1SLC6A4CHRNA7HCRTR1
SCHEMBL13724788 0.71 HPGD (0.45) SIGMAR1CYP1A2CYP2D6TACR1SLC6A4
SCHEMBL18474495 0.70 L3MBTL1 (0.50) SIGMAR1SLC6A4
SCHEMBL2484015 0.68 BIRC2 (0.38) SIGMAR1TACR1SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373657-A1 5, 7-DIHYDRO- 6H-PYRIMIDO Ý 5, 4-D¨Ý 1¨BENZAZEPIN-6-THIONES AS PLK INHIBITORS Millennium Pharmaceuticals, Inc. (US) 2011-10-12 EP disclosed
WO-2010065134-A1 5, 7-DIHYDRO- 6H-PYRIMIDO [ 5, 4-D] [ 1 ] BENZAZEPIN-6-THIONES AS PLK INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-10 WO disclosed